March 06, 2015 7:14 AM ET

Pharmaceuticals

Company Overview of Kos Pharmaceuticals, Inc.

Company Overview

Kos Pharmaceuticals, Inc. develops and commercializes prescription products for the treatment of chronic cardiovascular, metabolic, and respiratory diseases. Its products include Niaspan for the treatment of mixed lipid disorders; Advicor for the treatment of primary hypercholesterolemia and mixed dyslipidemia in patients previously treated with either component or who require additional lipid modification for LDL and HDL cholesterol, and triglycerides beyond that achieved by the individual components; and Azmacort product, an inhaled corticosteroid that alleviates inflammation in the lungs and is used as prophylactic therapy for the maintenance treatment of asthma. The company’s products al...

1 Cedar Brook Drive

Cranbury, NJ 08512-3618

United States

Founded in 1988

1,361 Employees

Phone:

609-495-0500

Fax:

609-495-0920

Key Executives for Kos Pharmaceuticals, Inc.

Co-Founder and Chairman Emeritus of the Board
Age: 85
Vice President Of Business Development And Licensing
Vice President of Sales
Vice President of Managed Care
Vice President of Aerosol Business Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Life Force International Corporation United States
Abeille Pharmaceuticals, Inc. United States
VPDC Inc. United States
Bartels, Inc. United States
Ion Laboratories, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kos Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.